Log in

Relevant bibliographies by topics / Bare Metal Stent (BMS)

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Bare Metal Stent (BMS)'

Author: Grafiati

Published: 3 June 2025

Last updated: 19 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Bare Metal Stent (BMS).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Bare Metal Stent (BMS)"

1

Mowakeaa, Samer, Aline Iskandar, and Nikolaos Kakouros. "Neoatherosclerosis in Very Late Stenosis of Bare Metal Stent by Optical Coherence Tomography." Case Reports in Cardiology 2016 (2016): 1–3. http://dx.doi.org/10.1155/2016/1652065.

Full text

Abstract:

Bare metal stents (BMS) continue to be widely used in patients with coronary artery disease undergoing percutaneous revascularization. Progressive luminal renarrowing has been reported late after BMS implantation resulting in a significant rate of stent failure events. We present a case of very late BMS failure due to in-stent restenosis where optical coherence tomography (OCT) was used to demonstrate neoatherosclerosis as the underlying mechanism. We provide a brief review of neoatherosclerosis and showcase salient features on OCT evaluation.

APA, Harvard, Vancouver, ISO, and other styles

2

Zhao, Yaping, Zhong Chen, Wayne W. Zhang, Sheng Wang, Yaoguo Yang, and Liao Yang. "Bioabsorbable Drug-Eluting Stent Versus Bare Metal Stent in Iliac Artery Evaluated by Optical Coherence Tomography: An In Vivo Study in Porcine." Vascular and Endovascular Surgery 52, no. 7 (2018): 512–19. http://dx.doi.org/10.1177/1538574418783528.

Full text

Abstract:

Objective: This study aimed to compare, using optical coherence tomography (OCT), the outcomes of bioabsorbable drug-eluting stent with those of bare metal stent (BMS) following implantation in porcine iliac artery. Methods: After the placement of BMS and bioabsorbable drug-eluting stents, we used OCT and digital subtraction angiography to investigate stent appositions, arterial neointima, evagination, and restenosis at 1 and 3 months. Results: At 1 and 3 months after stent implantation, OCT study was performed to investigate 32 stents and 21 788 struts. Thirty-three malapposed struts were fou

APA, Harvard, Vancouver, ISO, and other styles

3

Rao K, Raghavendra, S. Reddy, J. R. Kashyap, K. Vikas, Hithesh Reddy, and Vadivelu Ramalingam. "Acute Coronary Syndrome after 17 Years of Bare Metal Stent Implantation: “Very” Very Late Stent Thrombosis." Case Reports in Cardiology 2020 (February 6, 2020): 1–5. http://dx.doi.org/10.1155/2020/9628719.

Full text

Abstract:

Very late stent thrombosis (VLST) is a catastrophic and life-threatening complication after percutaneous coronary intervention which presents as an acute coronary syndrome with significantly high mortality and morbidity. VLST is a rare entity with drug-eluting stents and even rarer with bare metal stents. The exact pathophysiologic mechanism of VLST after BMS implantation is not known although various mechanisms have been proposed. Recently, in-stent neoatherosclerosis with intimal plaque rupture has been proposed as a potential mechanism of VLST after BMS. We report a rare case of VLST occurr

APA, Harvard, Vancouver, ISO, and other styles

4

Cornelissen, Anne, Liang Guo, Raquel Fernandez, et al. "Endothelial Recovery in Bare Metal Stents and Drug-Eluting Stents on a Single-Cell Level." Arteriosclerosis, Thrombosis, and Vascular Biology 41, no. 8 (2021): 2277–92. http://dx.doi.org/10.1161/atvbaha.121.316472.

Full text

Abstract:

Objective: Healing processes, particularly reendothelialization, are essential for vascular homeostasis after plain old balloon angioplasty and stent implantation. Drug-eluting stents (DES) are commonly used for percutaneous coronary intervention because restenosis rates are reduced as compared with bare metal stents (BMS). However, in addition to understanding the nature of regenerated endothelial cells, concerns over incomplete stent healing persist, and the molecular effects of antiproliferative drug coatings on endothelium remain poorly understood. Approach and Results: We used the rabbit

APA, Harvard, Vancouver, ISO, and other styles

5

Narbute, Inga, Sanda Jēgere, Indulis Kumsārs, et al. "Long-term Clinical Results for Randomised Comparison of Paclitaxel-eluting versus Bare-metal Stents in Unprotected Left Main Coronary Artery Disease." Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 63, no. 4-5 (2009): 243–48. http://dx.doi.org/10.2478/v10046-009-0037-2.

Full text

Abstract:

Long-term Clinical Results for Randomised Comparison of Paclitaxel-eluting versus Bare-metal Stents in Unprotected Left Main Coronary Artery Disease To optimise percutaneous coronary intervention (PCI) strategy for unprotected left main (ULMCA) disease we performed a randomised study: IVUS-guided bare metal stent (BMS) versus paclitaxel-eluting stent (PES) implantation after lesion pre-treatment with cutting balloon (CB) for unprotected LM lesions. The purpose of this randomized study was to evaluate six-month and three-year clinical results. Several recent publications have demonstrated good

APA, Harvard, Vancouver, ISO, and other styles

6

Leshkevich, Ch F., E. V. Kovsh, G. A. Sergeev, A. B. Maximchik, D. N. Boncevich, and I. E. Adzerikho. "ASSESSMENT OF INTERVENTION TREATMENT OF UNSTABLE ANGINA OF PATIENTS OF DIABETES MELLITUS TYPE 2." Health and Ecology Issues, no. 4 (December 28, 2008): 34–39. http://dx.doi.org/10.51523/2708-6011.2008-5-4-6.

Full text

Abstract:

The purpose of the study is a comparative assessment of the immediate and long-term results using Sirolimus - Eluting Stents (SES) and Bare-Metal Stent (BMS) in patients with unstable angina and diabetes mellitus type 2.

APA, Harvard, Vancouver, ISO, and other styles

7

Sabti, Zaid, and Raban Jeger. "Vollständig resorbierbare Stents – eine neue Ära in der Behandlung der koronaren Herzkrankheit?" Praxis 106, no. 2 (2017): 85–89. http://dx.doi.org/10.1024/1661-8157/a002584.

Full text

Abstract:

Zusammenfassung. Die perkutane Ballonangioplastie revolutionierte die Behandlung der koronaren Herzkrankheit. Der Einsatz von Gefässstützen (Stents) setzte diese Revolution fort. Nach den reinen Metallstents (Bare metal stents, BMS) und den Medikamenten-beschichteten Stents (drug-eluting stents, DES) folgen nun bioresorbierbare Stents (bioresorbable vascular scaffolds, BVS). Im Gegensatz zu den ersten zwei Stent-Generationen werden die BVS nach einer bestimmten Zeit vollständig abgebaut und versprechen eine Antwort für bisher ungelöste Probleme von BMS und DES.

APA, Harvard, Vancouver, ISO, and other styles

8

Apostolovic, Svetlana, Zoran Perisic, Miloje Tomasevic, Goran Stankovic, Milan Pavlovic, and Sonja Salinger-Martinovic. "Late thrombosis of coronary bare-metal stent: Case report." Srpski arhiv za celokupno lekarstvo 134, no. 3-4 (2006): 155–58. http://dx.doi.org/10.2298/sarh0604155a.

Full text

Abstract:

Stent thrombosis remains the primary cause of death after percutaneous coronary interventions (PCI). Despite modern concepts of PCI, stent thrombosis occurs in 0.5% -2% of elective procedures and even 6% of patients with the acute coronary syndrome (ACS). Stent thrombosis most often develops within the first 48 hours after the PCI, and rarely after a week of stent implantation. Angiographically documented late (>6 months) thrombosis of coronary bare-metal stent (BMS) is rare, because the stent endothelialization is considered to be completed after four weeks of the intervention. Our patient

APA, Harvard, Vancouver, ISO, and other styles

9

Kayani, Azhar Mahmood, Syed Nadeem Hassan Rizvi, Khusrow A. Niazi, et al. "CLINICAL EVALUATION OF THE INDIGENOUSLY MANUFACTURED REJUVENATE® BARE METAL STENT SYSTEM IN PAKISTANI PATIENTS WITH CORONARY ARTERY DISEASE." Pakistan Heart Journal 54, no. 3 (2021): 261–67. http://dx.doi.org/10.47144/phj.v54i3.2169.

Full text

Abstract:

Objectives: The aim of this pilot study was the ﬁrst-in-man evaluation of the safety, feasibility, deliverability, and efficiency of the newly developed REJUVENATE® bare metal stent system in coronary artery disease. Methodology: Current study was a pilot non-randomized, multi-centric and prospective study which was intended to study the safety of the REJUVENATE® bare metal stent in Pakistani population over 10 months. Study endpoints included target vessel related myocardial infarction, stent thrombosis, in-stent restenosis, stroke and death. The diameter of the target lesions selected was be

APA, Harvard, Vancouver, ISO, and other styles

10

Pradeepa, P., S. S. Murugan, Sangeetha V. Naveen, and T. S. Kumaravel. "Evaluation of Mechanical Hemolysis of Bare Metallic and Drug-Eluting Cardiovascular Stents." Indian Journal Of Science And Technology 18, no. 13 (2025): 1079–86. https://doi.org/10.17485/ijst/v18i13.645.

Full text

Abstract:

Objectives: To investigate the hemolytic potential of different types of experimental cardiovascular stents [Bare Metal Stents (BMS), Sirolimus Eluting Stents (SES), and Everolimus Eluting Stents (EES)] in an in vitro study using a bovine blood circulatory model. Methods : Fresh bovine blood was circulated through the loop containing the stents, using the peristaltic pump for 6 hours at 37°C at a constant flow of 200 mL/minute. Plasma Free Hemoglobin (PFH) was measured spectrophotometrically at defined intervals. The Normalized Index of Hemolysis (NIH) and the Modified Index of Hemolysis (MIH)

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Bare Metal Stent (BMS)"

1

Yamaji, Kyohei. "Bare-metal Stent Thrombosis and In-stent Neoatherosclerosis." Kyoto University, 2012. http://hdl.handle.net/2433/158059.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Ohya, Masanobu. "Long-Term Outcomes After Stent Implantation for Left Main Coronary Artery (from the Multicenter Assessing Optimal Percutaneous Coronary Intervention for Left Main Coronary Artery Stenting Registry)." Kyoto University, 2018. http://hdl.handle.net/2433/235034.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Frahnow, Andreas [Verfasser]. "Lebensqualitätsentwicklung nach Implantation von drug eluting stents im Vergleich zu bare metal stents : eine Analyse des Deutschen Drug Eluting Stent-Registers (DES.DE) / Andreas Frahnow." Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2019. http://d-nb.info/1202042147/34.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Sambola, Antonia, Pau Rello, Toni Soriano, et al. "Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis." Elsevier Ltd, 2020. http://hdl.handle.net/10757/655507.

Full text

Abstract:

Objective: A systematic review and meta-analysis was performed to evaluate the safety and efficacy of drug-eluting stents (DES) vs bare-metal stents (BMS) in atrial fibrillation (AF) patients. Methods: We systematically searched 5 engines until May 2019 for cohort studies and randomized controlled trials (RCTs). Primary outcomes were major bleeding and major adverse cardiac events (MACE) including cardiac death, myocardial infarction, target vessel revascularization (TVR) or stent thrombosis. Effects of inverse variance random meta-analyses were described with relative risks (RR) and their 95%

APA, Harvard, Vancouver, ISO, and other styles

5

RODRIGUES, Harley Fernandes. "Vetorização termoinduzida de nanopartículas magnéticas biocompatíveis: uma aplicação no recobrimento de Stents nus por via líquida." Universidade Federal de Goiás, 2011. http://repositorio.bc.ufg.br/tede/handle/tde/813.

Full text

Abstract:

Made available in DSpace on 2014-07-29T15:07:09Z (GMT). No. of bitstreams: 1 Dissertacao Harley Fernandes Rodrigues.pdf: 5566711 bytes, checksum: 484423a034c8d6a3a3f34650b5036af1 (MD5) Previous issue date: 2011-08-23<br>In this work we developed a Dip Coating method that could control the temperature gradient between a substrate and the material that one wants to adsorb at its surface. In particular, the adsorption of biocompatible magnetic nanoparticles at the surface of bare metal Stents, under different experimental conditions, was investigated. The magnetic nanoparticles consisted of mag

APA, Harvard, Vancouver, ISO, and other styles

6

Pavanello, Ricardo. "Efeitos da farmacoterapia utilizando doses máximas de clopidogrel e atorvastatina no controle da hiperplasia neointimal pós-implante de stent coronário." Universidade de São Paulo, 2012. http://www.teses.usp.br/teses/disponiveis/98/98131/tde-03082012-072458/.

Full text

Abstract:

Fundamentos: O implante de stents coronários constitui-se na técnica mais prevalente de revascularização percutânea, em especial pela prevenção da reestenose, quando comparado às intervenções com o balão. No entanto, a reestenose intra-stent, que ocorre em cerca de 25% dos casos, restringe os seus benefícios clínicos e econômicos tardios. Demonstrou-se que a hiperplasia neo-intimal decorrente da reação da parede vascular causada pelo implante do stent, é responsável pelas recidivas. Interroga-se se um protocolo de medicamentos contemplando doses máximas de manutenção de clopidogrel e atorvasta

APA, Harvard, Vancouver, ISO, and other styles

7

Lin, Yi-Ling, and 林宜玲. "Resources Utilization and Clinical Outcomes of Drug-Eluting Stent versus Bare Metal Stent in Coronary Artery Disease Patients." Thesis, 2006. http://ndltd.ncl.edu.tw/handle/93047288459082485059.

Full text

Abstract:

碩士<br>高雄醫學大學<br>醫務管理學研究所碩士班<br>94<br>ABSTRACT Background: Coronary artery disease (CAD) was the 3rd in top of ten death causes during 2000 to 2003 in Taiwan. However, it became the 2nd in 2004. Technology of percutaneous coronary intervention (PCI) is advancing very fast, and had improved the outcomes in treatment of patients with CAD, especially after using coronary stenting. However, the use of coronary stents was associated with unacceptable rates of restenosis, wich was improved significantely after the use of drug-eluting stents (DES). However, the overall clinical outcomes and resources

APA, Harvard, Vancouver, ISO, and other styles

8

Cheng, Chia-Ling, and 鄭佳玲. "Coronary artery disease therapy －Drug-Eluting stent & Bare Metal Stent on Clinical Outcomes and Resources Utilization Analysis." Thesis, 2007. http://ndltd.ncl.edu.tw/handle/13005656596870809790.

Full text

Abstract:

碩士<br>臺灣大學<br>醫療機構管理研究所<br>95<br>Purpose and Aim：Coronary artery disease (CAD) remains one of the most important health problems in the world. According to the statistical record from National Health Institute in Taiwan in 2005, the cardiovascular disease was the third leading cause of death; among them, the CAD was the major killer(event). The treatment of CAD has been proceeding since medical treatment, balloon angioplasty to coronary stents and resulted in major achievement. There are around ten thousand patients with CAD undergoing the implantation of coronary stents to keep adequate coron

APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Bare Metal Stent (BMS)"

1

Kahn, S. Lowell. Creation of a Flow-Modulating Stent Using Multilayered Wallstents for Aneurysm Exclusion. Edited by S. Lowell Kahn, Bulent Arslan, and Abdulrahman Masrani. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199986071.003.0011.

Full text

Abstract:

Abdominal aortic aneurysms (AAAs) are a common pathology that is found in 4–9% of patients in the developed world. Risk factors for AAAs include age, male sex, family history, comorbid cardiovascular disease, and smoking. Despite the male predominance of the disease, rupture occurs at a smaller diameter in females, and the outcomes are poorer in this subgroup. Flow-modulating stents are a relatively new development and consist of multilayered bare-metal self-expanding stents. Despite the inherent porosity of the stents, the interconnected stent matrix features flow-diverting properties that pr

APA, Harvard, Vancouver, ISO, and other styles

2

Sabri, Saher S. Recanalization of Occluded TIPS Using a Transhepatic Percutaneous Technique. Edited by S. Lowell Kahn, Bulent Arslan, and Abdulrahman Masrani. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199986071.003.0080.

Full text

Abstract:

Transjugular intrahepatic portosystemic shunt (TIPS) dysfunction rates have significantly decreased since the introduction of stent grafts. However, TIPS occlusion remains a recognized complication, especially when bare-metal stents are used or when the cephalad end of the stent does not extend into the inferior vena cava (IVC). Antegrade recanalization of the occluded TIPS can be routinely achieved using a coaxial or a triaxial sheath system, which provides sufficient stability and pushability to recanalize the TIPS. However, occasionally this cannot be achieved due to the difficult angulatio

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Bare Metal Stent (BMS)"

1

Shinke, Toshiro. "Bare-Metal Stent." In Coronary Angioscopy. Springer Japan, 2015. http://dx.doi.org/10.1007/978-4-431-55546-9_14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Kobayashi, Mayo, Yasuyuki Shiraishi, Francis Chikweto, et al. "In Vitro Modelling of Aortic Dissection for Bare-Metal Stent Intervention." In IFMBE Proceedings. Springer Nature Switzerland, 2024. https://doi.org/10.1007/978-3-031-80355-0_2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Rako, Duje. "Indications, Complications and Side Effects of Metallic Ureteral Stents." In Urinary Stents. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-04484-7_3.

Full text

Abstract:

AbstractFirst widely used ureteral stents were polymeric and first documented metallic stent placed in ureter was vascular permanent stent in patient with malignant obstruction. Due to high complication rates with off label bare metal stents and covered metal stents development of purpose-based urological metallic stents was started. They are nowadays usually exploited when longer indwelling times are envisioned due to benign conditions, malignant obstruction or post-radiotherapy. In our analysis we have witnessed high risk of complication—68% per patient and 50% per stent.Further research in form of multi-institutional prospective RCT in order to obtain better understanding of complications is needed which in turn can drive further development of stent materials, coatings and designs ultimately giving our patients better QoL.

APA, Harvard, Vancouver, ISO, and other styles

4

Caixeta, Adriano, Philippe Généreux, George Dangas, and Roxana Mehran. "In-stent restenosis in the drug-eluting stent era." In Oxford Textbook of Interventional Cardiology. Oxford University Press, 2010. http://dx.doi.org/10.1093/med/9780199569083.003.028.

Full text

Abstract:

For the last two decades, restenosis has been considered the most significant problem in interventional cardiology. Drug-eluting stents (DES) have reduced rates of restenosis and target lesion revascularization (TLR) by 50–90% compared with bare-metal stents (BMS) across all lesion and patient subsets. However, a small number of patients have in-stent restenosis (ISR) after DES treatment. DES efficacy has been limited by suboptimal polymer biocompatibility, suitability of pharmacological agents, suboptimal in vivo pharmacokinetic properties, and local drug resistance and toxicity. The first two DES (sirolimus-eluting stents [SES] and paclitaxel- eluting stents [PES]) have the longest clinical follow- up, whereas the zotarolimus-eluting stents [ZES], everolimus-eluting stents [EES], and biolimus-eluting stents [BES] have only recently been introduced in daily practice. Although the low frequency of ISR events with DES makes it difficult to fully investigate this syndrome, many studies have been conducted or are ongoing to find the mechanism, incidence, predictors, and optimal treatment of DES restenosis. This review discusses the data relevant to DES restenosis and the perspective on the current treatment of this condition.

APA, Harvard, Vancouver, ISO, and other styles

5

Abacı, Okay, and Ömer Doğan. "Koroner Stentler." In Tanıdan Tedaviye Koroner Girişimler. İstanbul Üniversitesi–Cerrahpaşa Üniversite Yayınevi, 2025. https://doi.org/10.5152/4822.

Full text

Abstract:

Perkütan koroner girişimler, ilk balon dilatasyonu uygulamalarından bu yana önemli teknolojik ilerlemeler kaydetmiştir. Akut damar tıkanıklıkları, bare-metal stentler (BMS) ile etkin bir şekilde çözümlenmiş ve daha sonra restenoz oranını minimize etmek amacıyla ilaç kaplı stentler (DES) geliştirilmiştir. Günümüzde mevcut olan DES'ler yüksek güvenlik ve etkinlik sağlasa da, stent trombozu ve restenoz riski tamamen ortadan kalkmış değildir. Stent tasarımında, radyal kuvveti korurken iletilebilirlik ve radyopasiteyi artıran iyileştirmeler gerçekleştirilmiştir, ancak prosedürel güvenliği ve başarıyı artırmak için daha düşük profilli cihazların geliştirilmesi araştırılmaya devam etmektedir. Biyolojik olarak emilebilir stentler teorik avantajlarına rağmen, geç stent trombozu ile ilgili güvenlik endişeleri nedeniyle geliştirilmeleri durdurulmuştur. Hem mevcut metal stent teknolojisindeki hem de gelecekteki biyolojik olarak emilebilir stentlerdeki ilerlemeler, kendi kendine genişleyen stentlerin gelişimine işaret etmektedir.

APA, Harvard, Vancouver, ISO, and other styles

6

Vasa-Nicotera, Mariuca, and Tony Gershlick. "Stent thrombosis." In Oxford Textbook of Interventional Cardiology. Oxford University Press, 2010. http://dx.doi.org/10.1093/med/9780199569083.003.029.

Full text

Abstract:

Over the past three decades, new strategies have rapidly evolved to achieve coronary reperfusion of ischaemic myocardium in patients with coronary artery disease (CAD). Studies comparing percutaneous coronary intervention (PCI) with coronary artery bypass grafting (CABG) have shown that the long-term rates of death and/or myocardial infarction (MI) are substantially the same, justifying the increasing and widespread use of PCI. PCI is the dominant reperfusion therapy for such patients with the ratio of numbers of PCIs undertaken to CABG performed being 4:1 in the United Kingdom and up to 8:1 in other parts of Europe. A recurrent issue during the evolution of PCI has been the difference between PCI and CABG in the percentage of patients requiring a repeat procedure (reintervention). To date, the need of reintervention has been less with CABG and this is due to the development of in-stent restenosis that occurs after PCI. Restenosis is the re-narrowing of the vessel, which requires a repeat procedure. The rate of restenosis with early balloon angioplasty has been high. The implantation of bare metal stents (BMS) and then drug-eluting stents (DES) has reduced significantly the incidence of restenosis. While such improved overall clinical outcomes with DES has supported the use of these in preference to BMS, another long-term complication has somewhat tempered the enthusiasm for their use: the possibility that implantation of DES would result in an excess of occlusive stent thrombosis (ST). This chapter will analyse the data on the incidence, causes, and clinical consequences of ST, and will outline the ongoing and future preventive and therapeutic initiatives. Finally, the risk/benefit of DES will be addressed.

APA, Harvard, Vancouver, ISO, and other styles

7

Louvard, Yves, and Thierry Lefèvre. "Coronary bifurcation stenting: state of the art." In Oxford Textbook of Interventional Cardiology. Oxford University Press, 2010. http://dx.doi.org/10.1093/med/9780199569083.003.018.

Full text

Abstract:

The difference between a coronary bifurcation lesion and an ordinary lesion lies in the presence of a side branch (SB). Such branches are particularly instrumental in the development of atheroma because of local blood flow patterns and are also a predictive factor of peri-procedural myocardial infarction (MI) when percutaneous coronary angioplasty (PCI) is performed. The clinical importance of a SB depends on its diameter which is strongly correlated with its flow and the muscular mass that it vascularizes; the diameter of the SB, main branch (MB), and of proximal segment of the MB are indeed interdependent as evidenced by Murray’s law. Therefore, a coronary bifurcation should be divided into three segments, each with its own reference diameter. Before the advent of coronary stenting, and later with bare-metal stents (BMS), PCI of coronary bifurcation lesions was associated with a lower success rate, a higher risk of complications, and a higher restenosis rate compared to non-bifurcation lesions. Although the use of drug-eluting stents (DES) has resulted in reduced restenosis rates and reintervention, coronary bifurcation lesions remain a higher risk setting especially when the bifurcation is proximal. Over the past few years, the subject of many debates has been the identification of optimal BMS or DES strategies for improving angiographic success, reducing the risk of peri-procedural complications, and decreasing the rate of restenosis and reintervention. The vast majority of registry studies (BMS and DES) and randomized studies (DES) have demonstrated that the systematic stenting of both branches is not superior to the strategy of ‘provisional side-branch stenting’. Indications for systematic double stenting as well as the type of strategy to be implemented are still being debated because of heterogeneous studies with respect to lesion type, and of the multiplicity of inadequately described or applied techniques. Adapting the technique to the lesion, as reported by several recent randomized studies, is complicated by the emergence of a new prognostic factor, namely the angle or angles of the bifurcation, which are still very difficult to measure precisely. Various types of ‘dedicated’ stents specifically designed for bifurcation lesions have been included in debates about the adaptation of the technique (or stent) to the type of bifurcation lesion to be treated. Finally, stenting of bifurcation lesions has been shown to be a risk factor of acute, late, or very late stent thrombosis and the influence of the technique or its imperfect implementation, has not been adequately assessed. The purpose of the present chapter is to provide an overview of coronary bifurcation lesions and their current treatment and address the fundamental as well as practical issues inherent in this setting.

APA, Harvard, Vancouver, ISO, and other styles

8

Malik, Nikesh, Amerjeet Banning, and Tony Gershlick. "Stent thrombosis." In Oxford Textbook of Interventional Cardiology, edited by Simon Redwood, Nick Curzen, and Adrian Banning. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198754152.003.0031.

Full text

Abstract:

Over the past three decades, new strategies have evolved to optimize coronary revascularization techniques. As such, both coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) have become standard treatments. Following the publication of trials showing a mortality benefit from CABG over PCI in only certain complex patient subsets, together with the clear central role of PCI in managing acute coronary syndromes, PCI has become the dominant mode of revascularization. The development of PCI has, however, been fraught with setbacks over the past 30 years. One critical issue in the early stages was the high restenosis rate, requiring a repeat procedure in up to one-third of patients. The development of bare metal stents and then drug-eluting stents (DES) dramatically reduced the incidence of restenosis now to less than 5%. While such improved clinical outcomes with DES have supported the widespread use of PCI, the issue of stent thrombosis remains a serious concern and hence the focus of continued research.

APA, Harvard, Vancouver, ISO, and other styles

9

Chandrasekhar, Jaya, Adriano Caixeta, Philippe Généreux, George Dangas, and Roxana Mehran. "In-stent restenosis in the drug-eluting stent era." In Oxford Textbook of Interventional Cardiology, edited by Simon Redwood, Nick Curzen, and Adrian Banning. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198754152.003.0030.

Full text

Abstract:

Since the inception of percutaneous coronary intervention, restenosis has been considered a significant problem. Although drug-eluting stents (DES) have reduced rates of in-stent restenosis (ISR) compared with bare metal stents across all lesion subsets, ISR has not been abolished. DES efficacy has been limited by suboptimal polymer biocompatibility, efficacy of pharmacological agents, in vivo pharmacokinetic properties, and local drug resistance and toxicity. While the first two DES to be manufactured (sirolimus- and paclitaxel-eluting stents) have the longest clinical follow-up, extensive data are now also available on zotarolimus- and everolimus-eluting stents. The uptake of biolimus-eluting stents has recently increased in clinical practice. Although the low frequency of DES ISR makes it difficult to investigate this condition fully, many studies have examined the mechanism, incidence, predictors, and optimal treatment of DES restenosis. This review discusses the data relevant to DES restenosis and the perspective on the current treatment of this condition.

APA, Harvard, Vancouver, ISO, and other styles

10

de Belder, Adam, and Martyn Thomas. "Rotational atherectomy." In Oxford Textbook of Interventional Cardiology. Oxford University Press, 2010. http://dx.doi.org/10.1093/med/9780199569083.003.033.

Full text

Abstract:

Since 1979, plain old balloon angioplasty (POBA) has provided relief of angina for many patients. Recurrent symptoms due to restenosis diminished with bare-metal stent and, more recently, drug-eluting technology. A limitation to achieving good results with POBA and stenting is calcification within the artery which not only can prevent passage of balloons and stents into a lesion but also may prevent adequate lumen expansion. Rotational atherectomy or rotablation (RA) can treat highly resistant calcified plaque within coronary arteries to allow adequate vessel expansion and ensure optimal stent deployment. The concept of using a high-speed diamond-tipped drill spinning at 150 000rpm driven by compressed air to clear an artery that is 3mm in diameter is challenging, yet this technique has been available for use in coronary arteries since 1989 when M.E. Bertrand (Lille, France) and R. Erbel (Essen, Germany) first used it in humans.

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Bare Metal Stent (BMS)"

1

Hou, Xiaoxi, Francis Chikweto, Yasuyuki Shiraishi, et al. "Finite Element Analysis of a Bare Metal Stent Therapeutic for Aortic Dissection." In 2024 46th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). IEEE, 2024. https://doi.org/10.1109/embc53108.2024.10782596.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Karanasiou, Georgia S., Vasileios S. Loukas, Nikolaos S. Tachos, et al. "In Silico Scenario of Bare Metal Stent and Drug-Eluting Stent Performance modeling in Patient-Specific Arteries: A Comparative Analysis." In 2024 46th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). IEEE, 2024. https://doi.org/10.1109/embc53108.2024.10782814.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Yazdani, Saami K., Qi Cheng, Debashis Dutta, Frank D. Kolodgie, and Renu Virmani. "A Polymer-Free Drug-Eluting Stent: In Vitro and In Vivo Analysis." In ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80147.

Full text

Abstract:

Drug-eluting stents (DES) have significantly improved restenosis rates as compared to bare metal stents (BMS), however, an increased risk in late stent thrombosis (LST) has been observed due to delayed healing and incomplete endothelialization. These adverse events have been associated to the high level of anti-proliferative drugs eluted from 1st generation DES, as well as non-erodible polymers that remain intact. The purpose of this study was to fist determine optimal surface modification in vitro and to then assess trends in endothelial coverage and recovery of the modified non-polymeric DES

APA, Harvard, Vancouver, ISO, and other styles

4

Mejia, Juan, Rosaire Mongrain, Richard Leask, Olivier F. Bertrand, and Josep Cabau-Rodes. "Transient and Non-Newtonian Effects on the Wall Shear Stress Distribution of a Stented Artery." In ASME 2009 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2009. http://dx.doi.org/10.1115/sbc2009-206735.

Full text

Abstract:

For the last few decades stents have played a central role in the treatment of artherosclerosis. Although bare-metal stents (BMS) have significantly reduced levels of restenosis rates by 20 or 30% [1], restenosis rates remain high at around 25% [1]. The introduction of drug-eluting stents have reduced restenosis rates even further [2], but are associated with high risk of late thrombosis [3].

APA, Harvard, Vancouver, ISO, and other styles

5

Wicaksono, Bonifasius Primario, Muhammad Kusumawan Herliansyah, and Widowati Siswomihardjo. "Ion Release of Stainless Steel 316L and Cobalt Chromium L605 Intravascular Bare Metal Stent: A Review." In 2017 5th International Conference on Instrumentation, Communications, Information Technology, and Biomedical Engineering (ICICI-BME). IEEE, 2017. http://dx.doi.org/10.1109/icici-bme.2017.8537764.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Garland, Lisa, David W. Holdsworth, and Ian A. Cunningham. "Enhancing bare metal stent visibility using multi-energy subtraction x-ray imaging." In Physics of Medical Imaging, edited by Rebecca Fahrig, John M. Sabol, and Lifeng Yu. SPIE, 2023. http://dx.doi.org/10.1117/12.2651570.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Buz, S., A. Navasardyan, A. Unbehaun, M. T. Nazari-Shafti, and V. Falk. "Positive Remodeling of the Aorta Using Bare Metal Stent in Acute Type B Aortic Dissection." In 48th Annual Meeting German Society for Thoracic, Cardiac, and Vascular Surgery. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1678812.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Gogineni, Aneesha, and T. S. Ravigururajan. "Flow Through Coated Coronary Stented Arteries: A Review." In ASME 2011 International Mechanical Engineering Congress and Exposition. ASMEDC, 2011. http://dx.doi.org/10.1115/imece2011-64621.

Full text

Abstract:

This paper reviews the recent literature on the stent applications and their recent advancements due to some controversies. The paper consists of two parts flow modeling of stents and a comparison between normal and stenosed artery. It also includes a comparison of stent geometries to determine hemodynamically favorable stents. In spite of many advantages bare metal stents are found to be unfavorable. However the study of stents based on flow and design recommend stent coatings. In comparison with bare metal stents, metal coated stents proved to be more efficient in terms of restenosis. Most o

APA, Harvard, Vancouver, ISO, and other styles

9

Shim, Hyung Jin, Dong Erk Goo, Seung Boo Yang, and Yong Jae Kim. "Bare Metal Stent for Central Venous stenosis/occlusion in Hemodialysis Patients: 5-year follow up study." In PAIRS Annual Meeting. Thieme Medical and Scientific Publishers Pvt. Ltd., 2018. http://dx.doi.org/10.1055/s-0041-1730712.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Geiger, Shannon B., Mark P. Golay, Benjamin G. Harless, et al. "Effect of Stent Design Parameters on Fluid and Structural Mechanics in Coronary Arteries." In ASME 2007 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2007. http://dx.doi.org/10.1115/sbc2007-176532.

Full text

Abstract:

As undergraduates at Virginia Polytechnic Institute and State University, our senior design team has been developing new arterial stent designs using computational, experimental and flow characterizations. Coronary artery stenting has become a popular alternative to bypass surgery due to its relatively low cost and short recovery time. There are approximately one million of these procedures performed each year. At the beginning of 2006, drug eluting stents (DES) accounted for 90% of stenting procedures; this number dropped below 75% by the end of 2006. The initial popularity of DES was due to

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Bare Metal Stent (BMS)"

1

Krastev, Plamen, Diana Trendafilova, Filip Abedinov, Iliyan Petrov, Peyo Simeonov, and Hristo Angelov. Drugeluting Stent versus Bare-metal Stent in Saphenous Grafts Angioplasty. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, 2019. http://dx.doi.org/10.7546/crabs.2019.06.16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!